Global Carotenoids Market to Reach $2.0 Billion by 2022

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
12
Global Carotenoids Market to Reach $2.0 Billion by 2022

WELLESLEY, Mass., May 21, 2018 (GLOBE NEWSWIRE) -- The commercial carotenoid market, led by product type astaxanthin, should continue to expand through 2022 at a modest growth rate. In a new report, The Global Market for Carotenoids, BCC Research estimates that this market will reach $2.0 billion by 2022, indicating a compound annual growth rate (CAGR) of 5.7%. Astaxanthin is anticipated to dominate the carotenoid industry with an 8.1% CAGR by 2022.

Carotenoids are chemical compounds produced by nature that have a physiological importance to the plants that produce them. Originally, carotenoids were used and commercialized as colors. Over the past decade, a better understanding of the function of carotenoids in living organisms has emerged, leading to their use as a nutritional additive with a more or less strong health claim. Carotenoids are used as coloring components in foods and feeds, occasionally in cosmetic products, and as physiologically active ingredients in nutritional supplements.

This report is an update of a 2015 BCC Research study. Although no new types of carotenoids have come on the market in the past two years and no fundamentally new manufacturing technology has been introduced, prices have changed significantly for a number of products and segments.

Research Highlights

  • Food was the carotenoid application with the highest market value (over $676.3 million) in 2016.
  • Europe had the highest market value in 2016 ($465.5 million), followed by North America at $370.5 million and Asia at $322.7 million.
  • Capsanthin had the largest market of any carotenoid in 2016 ($285.0 million) but is expected to drop behind market leader astaxanthin by 2022.

“While many types of carotenoids occur in nature, only 10 are used commercially: annatto, astaxanthin, beta-carotene, beta-apo-8-carotenal and its ester, canthaxanthin, lutein and its isomer zeaxanthin, lycopene and capsanthin/paprika. These products are either derived from botanical material or produced by fermentation or chemical synthesis,” said BCC Research analyst Andrew McWilliams, who authored the report.

About BCC Research BCC Research is a publisher of market research reports that provide organizations with intelligence to drive smart business decisions. By partnering with industry experts worldwide, BCC Research provides unbiased measurements and assessments of global markets covering major industrial and technology sectors, including emerging markets. For more information about BCC Research, please visit bccresearch.com . Follow BCC Research on Twitter at @BCCResearch .

Editors/reporters requesting analyst interviews should contact steven.cumming@bccresearch.com.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Features of the New HONOR Watch 5 Ultra

Updated Category News Views 404

Introducing the HONOR Watch 5 Ultra Global technology leader HONOR has unveiled its latest innovation, the HONOR Watch 5 Ultra, during a major tech event. This smartwatch marks a significant shift for the brand, highlighting its goals to expand beyond smartphones into a holistic AI device ecosystem. Emphasis on Consumer-Centric Technology HONOR is shifting its focus...

Continue Reading
Exploring MEXC's Explosive Token Growth and Trading Insights

Updated Category News Views 217

MEXC's Remarkable Token Performance MEXC, a prominent cryptocurrency exchange, has reported exceptional growth within its trading platform. The exchange highlights significant milestones and valuable market insights driven by the latest developments in the crypto ecosystem. In the past month, particularly notable has been the performance of newly listed tokens,...

Continue Reading
Understanding the Impacts of Dealing Disclosure at Life Science REIT Plc

Updated Category News Views 142

Overview of Disclosure in Finance The realm of finance is continuously guided by various regulations and codes to ensure that all market participants have access to transparent and accurate information. One such crucial regulation is Rule 8 of the Takeover Code. This rule mandates that any person with more than a certain percentage of interest in relevant securities...

Continue Reading
PMGC Holdings Inc. Enhances Business Alignment with New Names

Updated Category News Views 156

PMGC Holdings Announces Exciting Name Changes PMGC Holdings Inc., previously known as Elevai Labs Inc., has embarked on a new chapter with the recent renaming of its subsidiaries. This strategic decision reflects the company’s commitment to better align its operations with its diversified business goals. The name changes will reinforce PMGC's vision as a...

Continue Reading
Analysis of S&P 500 E-Mini Futures: Bulls vs. Bears Strategies

Updated Category News Views 107

Market Overview: S&P 500 E-mini Futures The current trading atmosphere for the S&P 500 E-mini futures is captivating, showcasing intricate movements where bulls strive for a significant breakout, while bears seek to establish solid selling positions. Observations from the recent weekly charts indicate that bears require a robust entry point, ideally with a bearish bar...

Continue Reading